Enzymatic and nonenzymatic formation of reactive oxygen species from 6-anilino-5,8-QUINOLINEQUINONE (cas 10470-83-4)
-
Add time:08/01/2019 Source:sciencedirect.com
The nonenzymatic and enzymatic formation of reactive oxygen species (ROS) from LY83583 (6-anilino-5,8-quinolinequinone) was investigated by electron paramagnetic resonance (EPR) spectroscopy. In the presence of thiol compounds such as glutathione and l-cysteine, LY83583 underwent a one-electron reduction due to low redox potential (−0.3±0.01 V vs. SCE), followed by formation of LY83583 semiquinone anion radical. This species was characterized by EPR spectroscopy under an argon atmosphere at neutral pH. Under an aerobic condition, this species interacts with molecular oxygen to form a superoxide anion radical. GSH-conjugated LY83583 was also identified by NMR and FAB-MS. When LY83583 was applied to PC12 cells, ROS formation was completely inhibited by both the flavoenzyme inhibitor DPI and the DT-diaphorase inhibitor dicumarol. On the other hand, ROS generation occurred independent of intracellular GSH level. These results indicate that LY83583 can generate ROS both enzymatically and nonenzymatically, although the enzymatic formation is dominant over the nonenzymatic system in PC12 cells.
We also recommend Trading Suppliers and Manufacturers of 5,8-QUINOLINEQUINONE (cas 10470-83-4). Pls Click Website Link as below: cas 10470-83-4 suppliers
Prev:The anti-cancer, anti-inflammatory and tuberculostatic activities of a series of 6,7-substituted-5,8-QUINOLINEQUINONE (cas 10470-83-4)s
Next:Analysis of quinolinequinone reactivity, cytotoxicity, and anti-HIV-1 properties) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Identification of two different Q-binding sites in QH2-cytochrome c oxidoreductase, using the Q analogue n-heptadecylmercapto-6-hydroxy-5,8-QUINOLINEQUINONE (cas 10470-83-4)08/04/2019
- The synthesis and evaluation of quinolinequinones as anti-mycobacterial agents08/03/2019
- Analysis of quinolinequinone reactivity, cytotoxicity, and anti-HIV-1 properties08/02/2019
- The anti-cancer, anti-inflammatory and tuberculostatic activities of a series of 6,7-substituted-5,8-QUINOLINEQUINONE (cas 10470-83-4)s07/31/2019


